Drugs / AP5346
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00415298 | May 2006 → ? | head and neck cancer | University of California, San Diego | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AP5346 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00415298 ↗ |
| Known as | DACH polymer platinate | “DACH polymer platinate AP5346” NCT00415298 ↗ |
| Modality | Other / unclassified | “DACH polymer platinate AP5346” NCT00415298 ↗ |
| Route | Intravenous | “Patients receive AP5346 IV over 2 hours three times daily on days 1 and 15.” NCT00415298 ↗ |